Philips shares jump 37% resulting in a $28.9 billion valuation
Philips will allocate $1.1 billion to address the costs related to their sleep therapy devices in response to user concerns about the potential cancer risk linked to the product.
https://fortune.com/europe/202....4/04/29/philips-shar
Discover the world at Altruu, The Discovery Engine